We have located links that may give you full text access.
JOURNAL ARTICLE
RESEARCH SUPPORT, NON-U.S. GOV'T
[The prevalence and risk factors of metabolic syndrome among adult residents in Guangdong and Jiangsu provinces in China].
OBJECTIVE: To determine the current prevalence and risk factors of metabolic syndrome (MS) among adult residents in Chinese developed areas.
METHODS: The clinical data of 6614 adult residents, including 4051 women, from Guangdong and Jiangsu provinces from China Diabetes and Metabolic Disorders Study (2007-2008) were analyzed. Age and sex standardized prevalences of MS were calculated according to the criteria of Chinese Diabetes Society (CDS), US National Cholesterol Education Program Adult Treatment Panel III (ATP III), International Diabetes Federation (IDF) and Joint Interim Statement (JIS), respectively. Logistic regression analysis was performed to identify the risk factors of MS.
RESULTS: Age and sex standardized prevalences of MS were 17.88% (CDS), 28.50% (ATPIII), 21.99% (IDF) and 31.50% (JIS), respectively. The prevalences of residents with at least one metabolic abnormality were 67.86% (CDS) 79.56% (ATPIII), 79.62% (IDF) and 80.74% (JIS), respectively. MS was more common in female than in male by the ATPIII and IDF criterion (ATPIII: 30.63% vs 26.45%, P < 0.01; IDF: 26.04% vs 17.91%, P < 0.01), while the prevalence was higher in male by CDS criteria (15.94% vs 19.87%, P < 0.01). There was no significant difference in the MS prevalence between the rural and the urban residents. Kappa test showed ATPIII and JIS criteria were most homogenous (κ = 0.95, P < 0.01). The risk factors for MS by the logistic regression model were male, older age, lower degree of education, family history of hypertension and obesity, drinker as well as uncontrolled diet.
CONCLUSION: The prevalence of MS is high in the adult residents of Chinese developed areas (Guangdong and Jiangsu provinces), whatever diagnostic criterion was used .Effective measures should be taken to control the modifiable MS risk factors.
METHODS: The clinical data of 6614 adult residents, including 4051 women, from Guangdong and Jiangsu provinces from China Diabetes and Metabolic Disorders Study (2007-2008) were analyzed. Age and sex standardized prevalences of MS were calculated according to the criteria of Chinese Diabetes Society (CDS), US National Cholesterol Education Program Adult Treatment Panel III (ATP III), International Diabetes Federation (IDF) and Joint Interim Statement (JIS), respectively. Logistic regression analysis was performed to identify the risk factors of MS.
RESULTS: Age and sex standardized prevalences of MS were 17.88% (CDS), 28.50% (ATPIII), 21.99% (IDF) and 31.50% (JIS), respectively. The prevalences of residents with at least one metabolic abnormality were 67.86% (CDS) 79.56% (ATPIII), 79.62% (IDF) and 80.74% (JIS), respectively. MS was more common in female than in male by the ATPIII and IDF criterion (ATPIII: 30.63% vs 26.45%, P < 0.01; IDF: 26.04% vs 17.91%, P < 0.01), while the prevalence was higher in male by CDS criteria (15.94% vs 19.87%, P < 0.01). There was no significant difference in the MS prevalence between the rural and the urban residents. Kappa test showed ATPIII and JIS criteria were most homogenous (κ = 0.95, P < 0.01). The risk factors for MS by the logistic regression model were male, older age, lower degree of education, family history of hypertension and obesity, drinker as well as uncontrolled diet.
CONCLUSION: The prevalence of MS is high in the adult residents of Chinese developed areas (Guangdong and Jiangsu provinces), whatever diagnostic criterion was used .Effective measures should be taken to control the modifiable MS risk factors.
Full text links
Trending Papers
A Personalized Approach to the Management of Congestion in Acute Heart Failure.Heart International 2023
Potential Mechanisms of the Protective Effects of the Cardiometabolic Drugs Type-2 Sodium-Glucose Transporter Inhibitors and Glucagon-like Peptide-1 Receptor Agonists in Heart Failure.International Journal of Molecular Sciences 2024 Februrary 21
The Effect of Albumin Administration in Critically Ill Patients: A Retrospective Single-Center Analysis.Critical Care Medicine 2024 Februrary 8
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app